In addition to microbial culture, cytology, and immunological studies, physicians rely on the clinical chemistry laboratory for biochemical analysis of patients' cerebrospinal fluid (CSF). However, apart from routine glucose and protein determinations, the clinical value of other CSF analytes is often unclear. Here, we review the literature pertaining to the use of CSF biochemical measurements in managing patients with infectious disease, neoplasia, stroke and trauma, and dementia. Although a small number of studies demonstrate potential usefulness of some markers, we conclude that, without further study, the data are insufficient to support the routine clinical use of most of the analytes examined. Our hope is that this review will familiarize the clinical laboratonan with the proposed utffity of numerous nontraditional CSF analytes, and that the laboratorian will thus be better able to help the clinician in making informed use of CSF biochemical analysis.
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a Tables 2-5 values". Part of this variability may be due to disparate assay techniques, but the concentrations of CSF analyte are dependent on the patient's age (9, 14, 15) and the sampling site (9, 12). Any value obtained must be interpreted in light of these variables. Changes in the biochemical composition of CSF are almost always a result of altered metabolic activity, cell death, or immune and inflammatory activity. With few exceptions, the substances that can be measured in CSF reflect these biological changes as sequelae to the actual pathological process rather than the process itself. Here we will review the biochemical basis and clinical performance of various substances that can be measured in CSF with respect to several categories of CNS pathologies.
Infectious Disease (Table 2) In evaluating a patient with suspected meningitis, the clinician must obtain a careful clinical history in addition to CSF cytology (leukocyte count and differential) and cultures (5, 6, 13 Simple, inexpensive assay.
"Bedside" assay available.
Present earlier in disease than pleocytosis.
Disadvantages
Influenced by serum concns.; insensitive (80%).
Insensitive and very nonspecific.
Redundant to glucose. response to make it diagnostically useful for distinguishing septic from aseptic meningitis.
Cytokines in CSF.
Inflammatory mediator cytokines such as tumor necrosis factor a (TNFa) and the interleukins (IL-2, IL-6) have also been examined for clinical utility in CNS infections.
One retrospective study (39) (42) . However, the variability was tremendous is unlikely that this marker will be useful for patient care (47 
